InVivo Therapeutics
VerifiedInVivo Therapeutics (NASDAQ:NVIV) is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries..
Launch date
Employees
Market cap
$981k
Net debt
$8.6m
Enterprise valuation
($8m) (Public information from Feb 2024)
Share price
$0.408 NVIV
Cambridge Massachusetts (HQ)